Mobara, Japan

Takafumi Kitano


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Mobara, JP (1980 - 1983)
  • Chiba, JP (1987 - 1989)

Company Filing History:


Years Active: 1980-1989

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Takafumi Kitano: Innovator of Cyclohexanone Derivatives

Introduction

Takafumi Kitano, hailing from Mobara, Japan, is a notable inventor with an impressive tally of eight patents. His work primarily focuses on advancing chemical compounds that have significant applications in pharmaceuticals.

Latest Patents

Among his latest innovations are the pyridyl-cyclohexanone compounds, which are represented by a specific general formula. These cyclohexanone derivatives serve as important intermediates for producing isoquinoline derivatives that play a crucial role in heart medications. Notably, one of his isoquinoline derivatives, structured with varying substituents like methyl and methoxymethyl groups, has shown low toxicity and high therapeutic potential as a cardiotonic medication.

Career Highlights

Takafumi Kitano has made substantial contributions to the field of chemistry through his role at Mitsui Toatsu Chemicals, Incorporated. His patented innovations underscore his expertise and dedication to creating chemical compounds that can enhance the safety and effectiveness of heart medications.

Collaborations

Throughout his career, Kitano has collaborated with esteemed colleagues, including Masahiko Maruyama and Makoto Hirayama. Their joint efforts and shared knowledge within the industry contribute to the success and impact of their inventions.

Conclusion

In conclusion, Takafumi Kitano's innovative work in the development of cyclohexanone and isoquinoline derivatives plays a vital role in the pharmaceutical industry, particularly in heart disease treatment. His commitment to research and collaboration highlights the importance of teamwork in the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…